Recent session action on shares of Actinium Pharmaceuticals, Inc. (:ATNM) puts the stock on today’s active list. Since the open, shares have moved 7.88% after recently hitting the $0.74 mark.
Digging a bit further, company shares have been noted -57.03% off the 52 week high and 37.11% away from the 52 week low. Looking at a shorter time period, shares have been seen -1.47% away from the 50 day high and 37.11% off the 50 day low price.Covering sell-side analysts have recently weighed in on shares of Actinium Pharmaceuticals, Inc. (:ATNM). At the time of writing, the First Call consensus price target for the company is $5.17. The current consensus recommendation provided by covering analysts is 2.00.
This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.
Since the beginning of the calendar year, the stock is -21.71%. For the quarter, shares have been noted at -34.76%. Share performance for the month is currently at 8.39%.
Tightening the gaze, stock performance for the last 5 trading days is -4.33%.